593P - Quality of life (QoL) analyses in patients with RAS wild-type (wt) metastatic colorectal cancer (mCRC) treated with first-line FOLFOX-4 ± cetuximab in the phase 3 TAILOR trial
| Autor: | Liu, T., Li, J., Xu, J., Wang, L., Cheng, Y., Chen, W., Chen, J., Pescott, C.P., Qin, S. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v201-v201 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|